Menu Search
Equities

Medical Properties Trust Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
MPW*:MEX

Medical Properties Trust Inc

Actions
  • Price (MXN)87.00
  • Today's Change0.00 / 0.00%
  • Shares traded9.00
  • 1 Year change-11.98%
  • Beta1.4342
Data delayed at least 20 minutes, as of Feb 05 2026 14:06 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Medical Properties Trust, Inc. is a self-advised real estate investment trust (REIT). The Company conducts all of its operations through its subsidiary, MPT Operating Partnership, L.P. It acquires and develops healthcare facilities and leases the facilities to healthcare operating companies under long-term net leases. It also makes mortgage loans to healthcare operators collateralized by their real estate assets. It selectively makes loans to certain of its operators through its taxable REIT subsidiaries (TRS). It has healthcare investments in the United States, Europe and South America. The Company owns hospital real estate with approximately 396 facilities and approximately 39,000 licensed beds in nine countries and across three continents. Its financing model facilitates acquisitions and recapitalizations and allows operators of hospitals to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.

  • Revenue in USD (TTM)933.52m
  • Net income in USD-707.95m
  • Incorporated2003
  • Employees118.00
  • Location
    Medical Properties Trust Inc1000 Urban Center Drive, Suite 501BIRMINGHAM 35242United StatesUSA
  • Phone+1 (205) 969-3755
  • Fax+1 (205) 969-3756
  • Websitehttps://medicalpropertiestrust.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.